EGF treatment also did not foster the formation of EpICD in whole-cell lysates or in cytoplasmic and nuclear extracts of Kyse30 and HCT8 cells (Fig 2G and 2H), so we conclude that EGFR-dependent RIP of EpCAM is not a common process in carcinoma cells. The gene discussed is EPCAM; the disease is carcinoma.